Five things for pharma marketers to know: Wednesday, October 17, 2018
Merck hires Nike exec as chief information, digital officer; Minnesota sues three insulin makers over pricing; UnitedHealth Q3 beats expectations.
-
-
Science behind Nobel winners spawned one of the biggest marketing duels in pharma history
The war on cancer took a big turn with the birth of checkpoint inhibitors. Laura Entis explores their scientific and commercial impact, the unanswered questions, and what’s next for this enormously successful group of immunotherapies. -
Trump orders drug companies to disclose list prices in DTC ads. Will it actually happen?
PhRMA pushed back on the HHS plan for disclosing drug prices in ads, putting itself in Trump’s Twitter crosshairs, but experts say flaws in the plan could impede its rollout anyway. -
Why healthcare agencies must redefine their role in philanthropic work
Agencies that view philanthropy merely as pro-bono work shortchange their people and are missing a chance to bring private-sector creativity to public health needs. -
Why pharma should start paying more attention to Instagram
Facebook Health’s Danielle Salowski and Merck’s Nancy Nolan shared best practices for Instagram at Digital Pharma East in Philadelphia.
LATEST NEWS
GSK moves global Panadol ad business from Grey to bespoke WPP team
WPP will create integrated campaigns and content encompassing advertising, digital, shopper activation and PR.
A timeline of key moments in the development of checkpoint inhibitors
Immunotherapy’s modern era has been characterized by a tremendous amount of scientific and regulatory activity. Trace the road to the Nobel.
Omnicom healthcare revenue up 2.9% in Q3
The holding company beat analysts’ estimates by reporting net income for its overall business was up more than 13% in the period.
Pharma firmly in the mix as healthcare embraces ‘open innovation’
Drugmakers are among the healthcare organizations working to make external collaboration more common.
Five things for pharma marketers to know: Tuesday, October 16, 2018
J&J Q3 beats expectations; Omnicom earnings impress investors; Feds to propose price disclosures in DTC ads.
Number of in-house agencies rise dramatically, ANA study finds
The trend continues as more complex offerings emerge in-house, but expansion and management of resources poses as one significant challenge.
Five things for pharma marketers to know: Monday, October 15, 2018
Trump administration will require list prices in DTC ads; FDA sets generic drug approval record in 2016; Lawmakers accepting money from drug distributors
Five things for pharma marketers to know: Friday, October 12, 2018
All the winners from MM&M Awards 2018; Trump reportedly considers Azar for attorney general; J&J cleared of liability in New Jersey talc trial.
Ashfield brings on Ben Beckley as first global commercial director
Beckley has worked at Havas Health & You and Precision Effect.
Worldwide Clinical Trials’ digital group wins Gold for Marketing Team
Executives from Calcium, GSK, and Silverlight Digital won individual awards.
